Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.77
+0.02 (+0.08%)
Streaming Delayed Price
Updated: 2:49 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
June 01, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
May 31, 2024
From
Pfizer Inc.
Via
Business Wire
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
May 30, 2024
Via
AB Newswire
Exposures
COVID-19
Creative Biolabs: The Way ADCs Are Made Has Changed
April 23, 2024
Via
Get News
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Wednesday Trading
April 17, 2024
Via
Investor Brand Network
Exposures
COVID-19
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024
From
Arvinas Inc.
Via
GlobeNewswire
3 Stocks That Suddenly Drew in Options Traders
May 13, 2024
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.
Via
MarketBeat
Study Questions Serious Flaws in $35 Million Antidepressant Research
March 22, 2024
CCHR says millions of taxpayer dollars are wasted on psychotropic drug research later found to be flawed and harmful to consumersLOS ANGELES - March 22, 2024 - PRLog -- Researchers have reanalyzed data...
Via
PRLog
Topics
Fraud
Exposures
Legal
Product Safety
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
May 08, 2024
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END
Via
FinancialNewsMedia
Generis Welcomes Max Kelleher as New Chief Executive Officer
May 14, 2024
LONDON - May 14, 2024 - PRLog -- Generis, creator of the cloud data, content, and business process management platform CARA™, today announced that Max Kelleher will be stepping into the role of Chief...
Via
PRLog
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
May 08, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Pfizer Announces New Chief Strategy and Innovation Officer
May 06, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
May 06, 2024
After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report
Via
MarketBeat
Exposures
COVID-19
Pfizer Reports First-Quarter 2024 Results
May 01, 2024
From
Pfizer Inc.
Via
Business Wire
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
From
Genmab A/S
Via
Business Wire
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
April 29, 2024
From
Pfizer Inc.
Via
Business Wire
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
April 26, 2024
From
Pfizer Inc.
Via
Business Wire
3 Bargain Stocks Near 52-week Lows
April 25, 2024
Three undeniable bargains came into play after the market's disappointment sell off, investors still have double-digit upside ahead of them in these names
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Pfizer Declares Second-Quarter 2024 Dividend
April 24, 2024
From
Pfizer Inc.
Via
Business Wire
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024
From
Pfizer Inc.
Via
Business Wire
Pneumococcal Pneumonia Vaccination Can Save Your Life
April 16, 2024
Via
StatePoint Media
QFunction: Cybersecurity Company Announces Launch of Customized AI Solutions
April 12, 2024
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
April 11, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
April 09, 2024
From
Pfizer Inc.
Via
Business Wire
4 Dividend Aristocrats Trading at a Discount
April 01, 2024
Near the end of the first quarter, a shift toward more defensive sectors occurred, prompting investors to buy fair-value dividend stocks like MO, T, F, and PFE
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Groundbreaking Documentary ‘Project Whistleblower’ Pulls Back the Curtain on Corporate Misconduct
March 30, 2024
Via
Press Release Distribution Service
Topics
Whistleblower
Exposures
Legal
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.